Understanding the Compatibility of Fluoride-Based Radiopharmaceutical Reaction Solutions and PDMS
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Microfluidic devices offer unique and exciting benefits when applied to radiopharmaceutical manufacturing, and these platforms are now starting to be integrated into commercial products. The field has strayed away from the use of polydimethylsiloxane (PDMS), the most common microfluidic device material, due to its suspected incompatibility with 18 F, the most commonly used radionuclide. However, existing literature provides conflicting conclusions as to the existence and extent of this incompatibility. In this study, we use several analytical instruments to uncover the underlying interaction between fluoride and PDMS. SEM imaging and profilometry confirm the reactive relationship between the two materials and suggest that this interaction only occurs when the reaction solution is fully evaporated and crystallized salts are in contact with PDMS. Furthermore, GC-MS identifies fluoride-containing volatile species that can account for loss of fluoride in previous studies and additionally reveals an incompatibility between PDMS and K 2 CO 3 (a commonly used component of radiofluorination reaction solutions). These results confirm the need for microfluidic radiofluorination devices to avoid the use of PDMS in most contexts but may allow for inexpensive design and testing of liquid state operations (such as concentration, purification, and mixing) using the material.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Microfluidic and Capillary Electrophoresis Applications · Innovative Microfluidic and Catalytic Techniques Innovation · Fluorine in Organic Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Interdisciplinary Materials Science
Vanderbilt University
Department of Biomedical Engineering
Cyclotron Radiochemistry Facility
The University of Texas MD Anderson Cancer Center
RADIATE R&D Platform
Department of Nuclear Medicine
Department of Mechanical Engineering
Funding
Vanderbilt University · U.S. Department of Health and Human Services · Cancer Prevention and Research Institute of Texas
References (22)
Show source-provided references
1. 10.2967/jnumed.109.06594610.2967/jnumed.109.065946 ↗
2. 10.1139/cjc-2012-033110.1139/cjc-2012-0331 ↗
3. 10.1109/JMEMS.2017.276412110.1109/JMEMS.2017.2764121 ↗
4. 10.1039/C8LC00167G10.1039/C8LC00167G ↗
5. 10.1007/s11307-020-01515-710.1007/s11307-020-01515-7 ↗
6. 10.1038/s41392-024-02041-610.1038/s41392-024-02041-6 ↗
7. 10.1039/D3LC00779K10.1039/D3LC00779K ↗
8. Tseng W.-Y. · 2010 · 2 · 472
9. 10.1002/macp.20150022510.1002/macp.201500225 ↗
10. 10.1016/j.mee.2019.11115710.1016/j.mee.2019.111157 ↗
11. 10.1116/1.146089610.1116/1.1460896 ↗
12. 10.1063/1.496471710.1063/1.4964717 ↗
13. 10.1016/j.snb.2017.07.06310.1016/j.snb.2017.07.063 ↗
14. 10.1007/s10404-019-2276-010.1007/s10404-019-2276-0 ↗
15. Frank C. · J. Nucl. Med. · 2018 · 59 · 67110.2967/jnumed.117.197426 ↗
16. 10.1186/s41181-019-0077-010.1186/s41181-019-0077-0 ↗
17. 10.1016/j.cej.2022.13498310.1016/j.cej.2022.134983 ↗
18. 10.1126/science.89.2304.17610.1126/science.89.2304.176 ↗
19. 10.1186/s41181-021-00143-y10.1186/s41181-021-00143-y ↗
20. 10.1038/s41598-020-72171-810.1038/s41598-020-72171-8 ↗
21. 10.1002/ejic.20210027510.1002/ejic.202100275 ↗
22. 10.1021/acs.langmuir.8b0158010.1021/acs.langmuir.8b01580 ↗